Breast Cancer Survivors Who Take Aspirin Have 50% Reduced Risk Of Metastasis
Economic Analysis Finds Erlotinib Marginally Cost-Effective For NSCLC
Racial Disparities Persist In Diagnosis Of Advanced Breast Cancer, Colon Cancer
Breast Cancer Rates Decline Most for Affluent White Women
Low Prevalence Of Tamoxifen Use For Cancer Prevention
Symptoms Don’t Help Detect Early-Stage Ovarian Cancer
Two-Week Break Balances RT Palliation, Side Effects
NCI Cooperative Group Clinical Trials Approved
Trending Stories
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Should I have a drink tonight?
In anticipation of the first holiday season since the surgeon general’s report on alcohol and cancer, we ask experts to weigh in - Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- The Cancer Letter’s most-read stories of 2025
As MAHA-led policies took hold, oncology navigated through uncertainty and turmoil - Mitochondrial-targeting drug attacks cancer cells from within
- With streamlined, “sitevisitless” CCSG review in place, cancer centers remained stable in 2025









